APA (7th ed.) Citation

JH, R., L, V., M, d. M., A, P., D, R., T, S., . . . P, B. (2023). Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial. Cell reports. Medicine, 4(12), 101307. https://doi.org/10.1016/j.xcrm.2023.101307

Chicago Style (17th ed.) Citation

JH, Rannikko, et al. "Bexmarilimab-induced Macrophage Activation Leads to Treatment Benefit in Solid Tumors: The Phase I/II First-in-human MATINS Trial." Cell Reports. Medicine 4, no. 12 (2023): 101307. https://doi.org/10.1016/j.xcrm.2023.101307.

MLA (9th ed.) Citation

JH, Rannikko, et al. "Bexmarilimab-induced Macrophage Activation Leads to Treatment Benefit in Solid Tumors: The Phase I/II First-in-human MATINS Trial." Cell Reports. Medicine, vol. 4, no. 12, 2023, p. 101307, https://doi.org/10.1016/j.xcrm.2023.101307.